PMC:7283670 / 42546-42582 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7283670","sourcedb":"PMC","sourceid":"7283670","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7283670","text":"4 (57.1%), immunoglobulin treatment:","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T135","span":{"begin":11,"end":25},"obj":"Body_part"}],"attributes":[{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T135","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T440","span":{"begin":0,"end":36},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T440","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#ecaa93","default":true},{"id":"LitCovid-sentences","color":"#9396ec"}]}]}}